Sparkling and vitamin waters seem like smart alternatives to soda, but research suggests that some ingredients—especially ...

Path of Exile 2 has a big 2026 ahead as Grinding Gear Games aims to launch version 1.0. Here's everything you can expect.

In the predawn darkness, a team of scientists climbs the slope of Mexico's Popocatépetl volcano, one of the world's most ...

Avocado oil is not a nutritional free pass. Here’s what the oil is, why it can be beneficial and why moderation still matters ...

Now that the condition is known to spread sexually, there are steps you and your partner can take to prevent it.

Stifel analysts said the label for cardiac myosin inhibitor Myqorzo is in line with their expectations and is differentiated compared with BMS’ Camzyos.

The US Food and Drug Administration has approved aficamten (Myqorzo), an allosteric cardiac myosin inhibitor, for adults with ...

Cytokinetics, Incorporated's (CYTK) shares surged 40.4% on Sept. 2, driven by positive results from a phase III study on cardiovascular candidate aficamten. On Aug. 30, Cytokinetics presented primary ...

During a medical event on Saturday, Cytokinetics (NASDAQ:CYTK) announced primary results from its Phase 3 MAPLE-HCM trial for lead asset aficamten in symptomatic obstructive hypertrophic ...

(RTTNews) - Cytokinetics, Incorporated (CYTK), Tuesday announced positive topline results from Phase 3 MAPLE-HCM study of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy ...

The U.S. Food and Drug Administration (FDA) on Thursday extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug Application (NDA) for Cytokinetics Inc's (NASDAQ:CYTK) ...